News

Park Medi World Limited, through its Registrar and Share Transfer Agent Kfin Technologies Limited, has submitted certificates to the BSE Limited and National Stock Exchange of India Limited under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, detailing securities dematerialized and rematerialized.

Park Medi World Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the announcement of the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in compliance with Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Park Medi World Limited announced that its Board of Directors approved the incorporation of a wholly-owned subsidiary, tentatively named “Park Medicity Prayagraj Limited” or “Park Hospital Prayagraj Limited,” as a Special Purpose Vehicle to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, under a Public-Private Partnership model awarded by the Prayagraj Municipal Corporation; the incorporation will involve a cash consideration of Rs 0.15 crore for 1,50,000 equity shares with a face value of Rs 10 each, and the company will hold 100% shareholding.

Park Medi World Limited announced August 31, 2026, that its Board of Directors approved the incorporation of a wholly-owned subsidiary, tentatively named “Park Medicity Prayagraj Limited” or “Park Hospital Prayagraj Limited,” as a Special Purpose Vehicle to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh, under a Public-Private Partnership model awarded by the Prayagraj Municipal Corporation; the subsidiary will have an authorized capital of Rs 0.15 crore, comprising 150,000 equity shares with a face value of Rs 10 each, and the company will hold 100% shareholding.

Net profit of Park Medi World rose 42.31% to Rs 82.51 crore in the quarter ended June 2026 as against Rs 57.98 crore during the previous quarter ended June 2025. Sales rose 19.27% to Rs 475.71 crore in the quarter ended June 2026 as against Rs 398.85 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales475.71398.85 19 OPM %26.5026.31 - PBDT123.9296.67 28 PBT105.0881.90 28 NP82.5157.98 42 Powered by Capital Market - Live News